je.st
news
China Biotech In Review: Novartis Has A Novel Scandal Potentially Brewing
2013-09-22 13:02:45| Biotech - Topix.net
Tianjin CanSino Biotech received a $10 million strategic investment from Lilly Asia Ventures, a venture capital arm of Lilly .
Tags: review
china
potentially
biotech
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|